Genesis Biotechnology Group has completed the acquisition of PharmOptima, which will enable the former to provide its customers a single point-of-contact for the development and co-ordination of their unique pre-clinical drug development programme.

"Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma."

The acquirer company is a US-based biotechnology firm, whereas the target company is a contract research organisation also based in the US.

Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma.

Both companies involved in the transaction are pharmaceutical organisations based in China.

The purchase consideration for the acquisition is expected to be ¥371.6m ($54.08m).

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.